Advances in predicting molecular classification of breast cancer by DCE-MRI quantitative enhancement parameters

Breast cancer is a highly heterogeneous malignant tumor. The patients with different molecular types of breast cancer have great differences in clinical treatment options, drug selection and prognosis evaluation. Therefore, if molecular typing can be accurately predicted by imaging examination, the best therapeutic regimen and accurate evaluation of prognosis can be provided in the early clinical stage, it also can avoid injury caused by pathological examination. The relationship between molecular typing and imaging quantitative parameters was reviewed. (authors)